329 related articles for article (PubMed ID: 16473681)
1. Expression of a novel gene, MafB, in Dupuytren's disease.
Lee LC; Zhang AY; Chong AK; Pham H; Longaker MT; Chang J
J Hand Surg Am; 2006 Feb; 31(2):211-8. PubMed ID: 16473681
[TBL] [Abstract][Full Text] [Related]
2. Gene expression analysis of Dupuytren's disease: the role of TGF-beta2.
Zhang AY; Fong KD; Pham H; Nacamuli RP; Longaker MT; Chang J
J Hand Surg Eur Vol; 2008 Dec; 33(6):783-90. PubMed ID: 18694919
[TBL] [Abstract][Full Text] [Related]
3. Androgen receptors in Dupuytren's contracture.
Pagnotta A; Specchia N; Greco F
J Orthop Res; 2002 Jan; 20(1):163-8. PubMed ID: 11853085
[TBL] [Abstract][Full Text] [Related]
4. Expression of bone morphogenetic proteins by Dupuytren's fibroblasts.
Shin SS; Liu C; Chang EY; Carlson CS; Di Cesare PE
J Hand Surg Am; 2004 Sep; 29(5):809-14. PubMed ID: 15465229
[TBL] [Abstract][Full Text] [Related]
5. Expression of matrix metalloproteinases and their inhibitors in cords and nodules of patients with Dupuytren's disease.
Ulrich D; Ulrich F; Piatkowski A; Pallua N
Arch Orthop Trauma Surg; 2009 Nov; 129(11):1453-9. PubMed ID: 18758795
[TBL] [Abstract][Full Text] [Related]
6. An integrated proteomics approach for studying the molecular pathogenesis of Dupuytren's disease.
Kraljevic Pavelic S; Sedic M; Hock K; Vucinic S; Jurisic D; Gehrig P; Scott M; Schlapbach R; Cacev T; Kapitanovic S; Pavelic K
J Pathol; 2009 Mar; 217(4):524-33. PubMed ID: 19089850
[TBL] [Abstract][Full Text] [Related]
7. Is Dupuytren's disease caused by an imbalance between proliferation and cell death?
Jemec B; Grobbelaar AO; Wilson GD; Smith PJ; Sanders R; McGrouther DA
J Hand Surg Br; 1999 Oct; 24(5):511-4. PubMed ID: 10597921
[TBL] [Abstract][Full Text] [Related]
8. Correlation of alpha-smooth muscle actin expression and contraction in Dupuytren's disease fibroblasts.
Tomasek J; Rayan GM
J Hand Surg Am; 1995 May; 20(3):450-5. PubMed ID: 7642925
[TBL] [Abstract][Full Text] [Related]
9. Tamoxifen decreases fibroblast function and downregulates TGF(beta2) in dupuytren's affected palmar fascia.
Kuhn MA; Wang X; Payne WG; Ko F; Robson MC
J Surg Res; 2002 Apr; 103(2):146-52. PubMed ID: 11922728
[TBL] [Abstract][Full Text] [Related]
10. Molecular phenotypic descriptors of Dupuytren's disease defined using informatics analysis of the transcriptome.
Rehman S; Salway F; Stanley JK; Ollier WE; Day P; Bayat A
J Hand Surg Am; 2008 Mar; 33(3):359-72. PubMed ID: 18343292
[TBL] [Abstract][Full Text] [Related]
11. Identification of histological patterns in clinically affected and unaffected palm regions in dupuytren's disease.
Alfonso-Rodríguez CA; Garzón I; Garrido-Gómez J; Oliveira AC; Martín-Piedra MÁ; Scionti G; Carriel V; Hernández-Cortés P; Campos A; Alaminos M
PLoS One; 2014; 9(11):e112457. PubMed ID: 25379672
[TBL] [Abstract][Full Text] [Related]
12. Comparison of gene expression profiles between Peyronie's disease and Dupuytren's contracture.
Qian A; Meals RA; Rajfer J; Gonzalez-Cadavid NF
Urology; 2004 Aug; 64(2):399-404. PubMed ID: 15302515
[TBL] [Abstract][Full Text] [Related]
13. Cytokine manipulation of explanted Dupuytren's affected human palmar fascia.
Kuhn MA; Payne WG; Kierney PC; Pu LL; Smith PD; Siegler K; Ko F; Wang X; Robson MC
Int J Surg Investig; 2001; 2(6):443-56. PubMed ID: 12678125
[TBL] [Abstract][Full Text] [Related]
14. Metalloproteinase gene expression correlates with clinical outcome in Dupuytren's disease.
Johnston P; Larson D; Clark IM; Chojnowski AJ
J Hand Surg Am; 2008 Sep; 33(7):1160-7. PubMed ID: 18762113
[TBL] [Abstract][Full Text] [Related]
15. Differences in alpha smooth muscle actin expression between fibroblasts derived from Dupuytren's nodules or cords.
Dave SA; Banducci DR; Graham WP; Allison GM; Ehrlich HP
Exp Mol Pathol; 2001 Oct; 71(2):147-55. PubMed ID: 11599921
[TBL] [Abstract][Full Text] [Related]
16. Identification of primary MAFB target genes in multiple myeloma.
van Stralen E; van de Wetering M; Agnelli L; Neri A; Clevers HC; Bast BJ
Exp Hematol; 2009 Jan; 37(1):78-86. PubMed ID: 19013005
[TBL] [Abstract][Full Text] [Related]
17. Beta-catenin overexpression in Dupuytren's disease is unrelated to disease recurrence.
Degreef I; De Smet L; Sciot R; Cassiman JJ; Tejpar S
Clin Orthop Relat Res; 2009 Mar; 467(3):838-45. PubMed ID: 18958538
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical evidence of nerve growth factor in Dupuytren's diseased palmar fascia.
Lubahn JD; Pollard M; Cooney T
J Hand Surg Am; 2007 Mar; 32(3):337-42. PubMed ID: 17336840
[TBL] [Abstract][Full Text] [Related]
19. Wnt expression is not correlated with beta-catenin dysregulation in Dupuytren's Disease.
O'Gorman DB; Wu Y; Seney S; Zhu RD; Gan BS
J Negat Results Biomed; 2006 Aug; 5():13. PubMed ID: 16942611
[TBL] [Abstract][Full Text] [Related]
20. Identification of biomarkers in Dupuytren's disease by comparative analysis of fibroblasts versus tissue biopsies in disease-specific phenotypes.
Shih B; Wijeratne D; Armstrong DJ; Lindau T; Day P; Bayat A
J Hand Surg Am; 2009 Jan; 34(1):124-36. PubMed ID: 19121738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
